Evaluating the efficacy and safety of Telitacicept vs. Rituximab in adult patients with pemphigus: a clinical trial (ChiCTR) - Oct 16, 2026 - P=N/A | N=40 | Completed | Sponsor: Affiliated Dermatology Hospital of Shandong First Medical University; Affiliated Dermatology Hospital of Shandong First Medical University
New trial
|